Castle Rock Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $323K | Buy |
+13,220
| New | +$323K | 0.08% | 200 |
|
2024
Q4 | – | Sell |
-6,881
| Closed | -$203K | – | 256 |
|
2024
Q3 | $203K | Sell |
6,881
-5,517
| -44% | -$163K | 0.05% | 240 |
|
2024
Q2 | $350K | Buy |
12,398
+1,423
| +13% | +$40.2K | 0.09% | 180 |
|
2024
Q1 | $298K | Sell |
10,975
-18,528
| -63% | -$504K | 0.08% | 191 |
|
2023
Q4 | $863K | Buy |
29,503
+1,327
| +5% | +$38.8K | 0.26% | 108 |
|
2023
Q3 | $935K | Buy |
28,176
+3,406
| +14% | +$113K | 0.31% | 79 |
|
2023
Q2 | $903K | Buy |
24,770
+17,040
| +220% | +$621K | 0.31% | 71 |
|
2023
Q1 | $297K | Buy |
7,730
+1,728
| +29% | +$66.5K | 0.11% | 168 |
|
2022
Q4 | $266K | Buy |
+6,002
| New | +$266K | 0.12% | 182 |
|
2022
Q3 | – | Sell |
-4,701
| Closed | -$251K | – | 213 |
|
2022
Q2 | $251K | Buy |
4,701
+10
| +0.2% | +$534 | 0.13% | 172 |
|
2022
Q1 | $235K | Sell |
4,691
-728
| -13% | -$36.5K | 0.11% | 205 |
|
2021
Q4 | $286K | Buy |
5,419
+9
| +0.2% | +$475 | 0.12% | 202 |
|
2021
Q3 | $261K | Sell |
5,410
-346
| -6% | -$16.7K | 0.09% | 223 |
|
2021
Q2 | $277K | Buy |
5,756
+212
| +4% | +$10.2K | 0.1% | 209 |
|
2021
Q1 | $214K | Buy |
+5,544
| New | +$214K | 0.09% | 235 |
|
2018
Q1 | – | Sell |
-6,629
| Closed | -$228K | – | 111 |
|
2017
Q4 | $228K | Buy |
+6,629
| New | +$228K | 0.44% | 86 |
|